Literature DB >> 1831501

Interleukin-6 production by human gingival fibroblasts.

P M Bartold1, D R Haynes.   

Abstract

The ability of human gingival fibroblasts to synthesize interleukin-6 (IL-6) was studied using in vitro and immunohistochemical techniques. Culture supernatants of human gingival fibroblasts contained significant quantities of IL-6 activity which could be stimulated by fetal calf serum, recombinant interleukin-1 beta and lipopolysaccharide. The activity in the supernatants was specifically attributed to IL-6 since up to 97% of the activity could be inhibited by an anti-IL-6 antibody. Immunohistochemical studies on low-density human gingival fibroblast cultures indicated that the cells were associated with material reactive to the anti-IL-6 antibody. This localization was seen on the cell surface and in the cytoplasm of the cells. Immunoreactivity towards IL-6 was also noted in sections of human gingivae. Moderate staining was seen in the connective tissues and lower portions of the gingival epithelium, while intense staining was seen at foci of inflammation. The identification of IL-6 with human gingival tissues and cells implicates this lymphokine in the molecular events associated with the inflammatory periodontal diseases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1831501     DOI: 10.1111/j.1600-0765.1991.tb02072.x

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  31 in total

1.  Variability of inflammatory mediator production by human periodontal fibroblasts stimulated with bacterial lipopolysaccharide.

Authors:  S Koka; R Reinhardt; C Maze; J Dyer
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-10       Impact factor: 2.416

2.  Use of defined mutants to assess the role of the Campylobacter rectus S-layer in bacterium-epithelial cell interactions.

Authors:  B Wang; E Kraig; D Kolodrubetz
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

3.  Human gingival fibroblasts rescue butyric acid-induced T-cell apoptosis.

Authors:  Tomoko Kurita-Ochiai; Kuniyasu Ochiai; Naoto Suzuki; Kichibee Otsuka; Kazuo Fukushima
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

4.  Compromised inflammatory cytokine response to P. gingivalis LPS by fibroblasts from inflamed human gingiva.

Authors:  Tracy R Fitzsimmons; Shaohua Ge; P Mark Bartold
Journal:  Clin Oral Investig       Date:  2017-07-08       Impact factor: 3.573

5.  Effect of topical simvastatin (1.2 mg) on gingival crevicular fluid interleukin-6, interleukin-8 and interleukin-10 levels in chronic periodontitis - A clinicobiochemical study.

Authors:  Harpreet Singh Grover; Shalini Kapoor; Ajita Singh
Journal:  J Oral Biol Craniofac Res       Date:  2015-12-05

6.  The Effect of Platform Switching on Periimplant Crevicular Fluid Content During Early Wound Healing.

Authors:  Hua-Hong Chien; Hsiu-Wan Meng; Amy C Gross; Timothy D Eubank; Vedat O Yildiz; Binnaz Leblebicioglu
Journal:  Implant Dent       Date:  2016-10       Impact factor: 2.454

7.  Lipopolysaccharides of Bacteroides intermedius (Prevotella intermedia) and Bacteroides (Porphyromonas) gingivalis induce interleukin-8 gene expression in human gingival fibroblast cultures.

Authors:  M Tamura; M Tokuda; S Nagaoka; H Takada
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

8.  The prostaglandin E1 analogue, misoprostol, regulates inflammatory cytokines and immune functions in vitro like the natural prostaglandins E1, E2 and E3.

Authors:  D R Haynes; M W Whitehouse; B Vernon-Roberts
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

9.  Is aspirin a prodrug for antioxidant and cytokine-modulating oxymetabolites?

Authors:  D R Haynes; P F Wright; S J Gadd; M W Whitehouse; B Vernon-Roberts
Journal:  Agents Actions       Date:  1993-05

10.  LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin.

Authors:  T Nagasawa; H Kobayashi; M Kiji; M Aramaki; R Mahanonda; T Kojima; Y Murakami; M Saito; Y Morotome; I Ishikawa
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.